DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN
Patent No. 598465 Disclosed is the use of a therapeutic combination comprising: (a) Compound (1) or a pharmaceutically acceptable salt thereof: (b) an interferon alpha; and (c) ribavirin, in the preparation of a medicament for treating hepatitis C viral (HCV) infection or alleviating one more sympto...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | STERN, JERRY O STEINMANN, GERHARD HAEFNER, CARLA |
| description | Patent No. 598465 Disclosed is the use of a therapeutic combination comprising: (a) Compound (1) or a pharmaceutically acceptable salt thereof: (b) an interferon alpha; and (c) ribavirin, in the preparation of a medicament for treating hepatitis C viral (HCV) infection or alleviating one more symptoms thereof in a patient, wherein the first dose of Compound (1), or a pharmaceutically acceptable salt thereof, is formulated for administration to the patient double in quantity by weight to the subsequent doses thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ598465A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ598465A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ598465A3</originalsourceid><addsrcrecordid>eNqFysEKgkAQgGEvHaJ6hZgHKKhspY6jju5Azsq4CHURie0UJdj7U0H3Tj_8fNOoy12DJYFSyRVJA4VTsFkLmatSFvTsBLwlxfr8fbVyw1JCyrvNNo7NClg8aUH6cXiqLQJKDsoptqws82hy6-9jWPw6i5YF-cyuw_Dswjj01_AIr04u5njYJwbjv-AN478xmA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN</title><source>esp@cenet</source><creator>STERN, JERRY O ; STEINMANN, GERHARD ; HAEFNER, CARLA</creator><creatorcontrib>STERN, JERRY O ; STEINMANN, GERHARD ; HAEFNER, CARLA</creatorcontrib><description>Patent No. 598465 Disclosed is the use of a therapeutic combination comprising: (a) Compound (1) or a pharmaceutically acceptable salt thereof: (b) an interferon alpha; and (c) ribavirin, in the preparation of a medicament for treating hepatitis C viral (HCV) infection or alleviating one more symptoms thereof in a patient, wherein the first dose of Compound (1), or a pharmaceutically acceptable salt thereof, is formulated for administration to the patient double in quantity by weight to the subsequent doses thereof.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131025&DB=EPODOC&CC=NZ&NR=598465A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131025&DB=EPODOC&CC=NZ&NR=598465A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STERN, JERRY O</creatorcontrib><creatorcontrib>STEINMANN, GERHARD</creatorcontrib><creatorcontrib>HAEFNER, CARLA</creatorcontrib><title>DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN</title><description>Patent No. 598465 Disclosed is the use of a therapeutic combination comprising: (a) Compound (1) or a pharmaceutically acceptable salt thereof: (b) an interferon alpha; and (c) ribavirin, in the preparation of a medicament for treating hepatitis C viral (HCV) infection or alleviating one more symptoms thereof in a patient, wherein the first dose of Compound (1), or a pharmaceutically acceptable salt thereof, is formulated for administration to the patient double in quantity by weight to the subsequent doses thereof.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFysEKgkAQgGEvHaJ6hZgHKKhspY6jju5Azsq4CHURie0UJdj7U0H3Tj_8fNOoy12DJYFSyRVJA4VTsFkLmatSFvTsBLwlxfr8fbVyw1JCyrvNNo7NClg8aUH6cXiqLQJKDsoptqws82hy6-9jWPw6i5YF-cyuw_Dswjj01_AIr04u5njYJwbjv-AN478xmA</recordid><startdate>20131025</startdate><enddate>20131025</enddate><creator>STERN, JERRY O</creator><creator>STEINMANN, GERHARD</creator><creator>HAEFNER, CARLA</creator><scope>EVB</scope></search><sort><creationdate>20131025</creationdate><title>DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN</title><author>STERN, JERRY O ; STEINMANN, GERHARD ; HAEFNER, CARLA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ598465A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>STERN, JERRY O</creatorcontrib><creatorcontrib>STEINMANN, GERHARD</creatorcontrib><creatorcontrib>HAEFNER, CARLA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STERN, JERRY O</au><au>STEINMANN, GERHARD</au><au>HAEFNER, CARLA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN</title><date>2013-10-25</date><risdate>2013</risdate><abstract>Patent No. 598465 Disclosed is the use of a therapeutic combination comprising: (a) Compound (1) or a pharmaceutically acceptable salt thereof: (b) an interferon alpha; and (c) ribavirin, in the preparation of a medicament for treating hepatitis C viral (HCV) infection or alleviating one more symptoms thereof in a patient, wherein the first dose of Compound (1), or a pharmaceutically acceptable salt thereof, is formulated for administration to the patient double in quantity by weight to the subsequent doses thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_NZ598465A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T02%3A08%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STERN,%20JERRY%20O&rft.date=2013-10-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ598465A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |